Pre-Presentation and Pre-Care Seeking

Artificial Intelligence Prevention, Outreach, and Screening Pre-Presentation and Pre-Care Seeking Presentation and Care-Seeking Triage, Sample Collection and Transport Diagnosis and drug-susceptibility testing Treatment Initiation and Patient Management Follow-Up and Post-Survival Support ICT, Data Systems, and Dashboard

 

  • One third of the world’s population is estimated to have latent TB infection (LTBI); meaning, they do not have active TB disease but may develop it through a process of reactivation of dormant bacilli that start multiplying and produce active TB.
  • The WHO strongly recommends treatment for latent TB infection in two priority groups: people living with HIV, and children aged under 5 years who are household contacts of someone who has bacteriologically confirmed pulmonary TB.
  • They also suggest BCG vaccination be provided as part of national childhood immunization programs according to a country’s TB epidemiology.
  • Individuals with TB may ignore or discount symptoms or may be unsure where to turn for screening, all of which delay diagnosis and treatment and increase risk of transmission. Cost of care also reduces access and care seeking for some. At least half of the world’s population lacks access to essential health services and almost 10% experience catastrophic expenditures on health.  For many, the stigma associated with TB and the lack of understanding of the importance of early detection and treatment also delay care seeking.
  • Several technologies have been developed for individuals with TB. Digital apps enable self-directed (algorithm-based) or physician led pre-screening (telemedicine). Digital health tools and virtual networks serve to educate and reduce stigma.  Websites maintained by NGOs serve as resources for individuals and providers.
  • Additionally, community health workers may lack experience with or knowledge about TB.
  • Other technologies target health care practitioners and provide guidance and resources for effectively diagnosing and treating TB.

Avegen is a Private Non-Government health-tech startup based in London and Mumbai, providing solutions that transform out-of-hospital specialist care. Together For Her health is an offering under Avegen’s maternal health platform.

Together for Her Health was developed to improve maternity health experiences in India. Together for Her Health provides an online platform for pregnant women to select hospitals based on reviews provided by new mothers on quality of care experiences at the maternity hospital. Together also provides information around quality of care indicators to help pregnant women and their families make this choice. The platform partners with healthcare providers and maternity hospitals in understanding and uplifting maternity health care across India: Togetherforherhealth Product

Doctor on Demand, Inc. is a private US-based Application Software company that market a telehealth platform. Doctor On Demand, Inc. does not itself provide any physician, mental health or other healthcare provider services.

The Doctor on Demand application provides face-to-face doctor consultations for patients with certain medical conditions,  with or without insurance, through their phone, computer or tablet. Patients pay one set fee for medical visits, while psychological services cost different amounts depending on the different treatments received: Doctorondemand Product

Docturnal Private Limited is an Indian private non-governmental company registered in Hyderabad. Docturnal is a point of care screening and diagnostics provider for non-invasive and proactive detection of diseases. Its flagship product is TimBre – a solution for TB screening and detection. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component.

It is a TB Screening app, where the sound of cough of an individual is recorded by a medical practitioner along with their demographic, clinical and socio-economic variables and processed in real time, leveraging machine learning to detect if the cough is TB positive or negative: Timbre Product

emocha® Mobile Health, Inc. is an US private IT Services company that market products first developed by researchers at the Johns Hopkins Center for Clinical Global Health Education designed to improve medication adherence using video technology and human engagement. emocha products leverage a CDC-endorsed model called Directly Observed Therapy (DOT) where healthcare workers watch patients take every dose of medication, monitor side effects, and provide critical support. The emocha platform is also capable of monitoring and enhancing health campaigns not only against TB but also other high-profile conditions.

emocha makes DOT more accessible through an asynchronous video DOT platform that enables engagement beyond in-person visits. Backed by world-renowned clinical experts and data from the National Institutes of Health, emocha is the leading adherence platform: emocha Product

Explain TB! was developed by clinicians at the Research Center Borstel through funding from the Tuberculosis Association Schleswig-Holstein and the German Central Committee against Tuberculosis. Other partners include the Robert-Koch-Institute Berlin, the German Center for Infection Research DZIF, the German Ministry of Health, the patient support group TakeThatTB and the tuberculosis research network TB-NET.

ExplainTB! is a crowd-funded series of education videos about tuberculosis delivered in the patient’s mother tongue. The central element is a freely available QR-code poster that allows point-of-care access to educational films in several languages. These posters can be freely downloaded from the www.ExplainTB.org. The website also provides further complimentary written information for patients. A smartphone app also allows access to the films without QR-code scanning. The app enables the physician to tailor the films from the video library to the patient’s needs: Explain TB! Product

HIVSmart! was created by a team of scientists and physicians at the Research Institute of the McGill University Health Centre (RI-MUHC), in partnership with the International Association of Providers of AIDS Care (IAPAC) and digital health social enterprise, Sympact-X.

HIVsmart! is an open-access mobile app that can be used to encourage people in any community to get tested for HIV. The application guides an individual through the process of performing their own HIV screening test, which consists of obtaining an oral fluid sample from the gum lining of their mouth. This non-invasive, simple test can detect the presence of HIV antibodies within 20 minutes and can be conducted in the privacy of one’s own home. HIVsmart! users are also provided with information, instructional videos, a 24 hour help line and confidential linkages to healthcare facilities and access to counsellors should they have a positive test: HIVSmart! Product

MomConnect is a South African National Department of Health programme with over 20 partners from the public and private sectors.

MomConnect aims to support maternal health through the use of cell phone based technologies integrated into maternal and child health services. The services are free to the user, and messages are available in all 11 official languages. It includes stage-based health messages developed by the National Department of Health with support from our expert partners at Baby Center, a text-based helpdesk that provides answers to pressing questions, a library of health information accessed via a USSD menu, and a service rating feature that allows subscribers to report on the quality of services they receive at facilities. Integrating directly with the national health system, MomConnect presents decision-makers with control interfaces and dashboards to ensure that feedback from mothers reaches the highest levels of government. MomConnect Product

The Novartis Foundation is a philanthropic organization aiming to have a sustainable impact on the health of low-income communities. For the Ghana Telemedicine Program, the foundation partnered with Millennium Promise Alliance, Earth Institute, Columbia University, the Ghana Ministry of Health, Ministry of Communication, National Health Insurance Agency, and Ambulance Service, St. Martin’s Hospital, MedGate, Ericsson and Airtel.

The Ghana Telemedicine Program uses information and communications technology (ICT) to connect community health workers to medical specialists via 24-hour teleconsultation centers. Doctors, nurses and midwives in the teleconsultation centers coach community health workers and advise on the treatment of their patients, helping them manage emergency cases that are beyond their capacity and avoiding unnecessary referrals. Ghana Telemedicine Program

ResApp Heath Limited is an Australian private Application Software company that develops easy to use, affordable, clinically-validated and regulatory-cleared diagnostic tools that only require a smartphone. ResApp solutions include applications that provide respiratory disease diagnosis and management directly to consumers and healthcare providers.

ResApp has developed smartphone-based machine learning algorithms that accurately identify acute exacerbations in patients with asthma or COPD. ResAppHealth Products

Twilio Inc. is a private US-based Infrastructure Software company that develops and publishes internet infrastructure solutions.

Twilio.org is the social impact arm of Twilio, Inc. and connects social impact organizations, passionate software developers, and the full power of the Twilio platform to ignite positive change on a local to global scale. Twilio.org provides technical, financial, and strategic support to help organizations reach communities using the same technology that private sector disruptors use to serve their customers. Twilio Products